A 'cocoon immunization strategy' among patients with inflammatory bowel disease

European Journal of Gastroenterology and Hepatology

Volumn 27, Issue 3, 2015, Pages 249-253

  Waszczuk, Karolina ^a   Waszczuk, Ewa ^a   Mulak, Agata ^a   Szenborn, Leszek ^a   Paradowski, Leszek ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

household children; immunization; infectious diseases; inflammatory bowel disease

Indexed keywords

CHICKENPOX VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE; VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHICKENPOX; CROHN DISEASE; CROSS-SECTIONAL STUDY; DISEASE DURATION; EDUCATIONAL STATUS; FEMALE; GROUPS BY AGE; HEALTH INSURANCE; HEALTH SURVEY; HOSPITAL PATIENT; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT REFUSAL; ULCERATIVE COLITIS; VACCINATION; CHILD; COMPLICATION; DECISION MAKING; FAMILY HEALTH; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; INFANT; MIDDLE AGED; NEWBORN; OPPORTUNISTIC INFECTIONS; PARENT; PATIENT ATTITUDE; POLAND; PRESCHOOL CHILD; PSYCHOLOGY; STANDARDS; STATISTICS AND NUMERICAL DATA; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DECISION MAKING; EDUCATIONAL STATUS; FAMILY HEALTH; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INFANT, NEWBORN; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; POLAND; VACCINATION; YOUNG ADULT;

EID: 84922397626     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000280     Document Type: Article

References (28)

1. Ananthakrishnan AN, McGinley EL. Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. J Crohns Colitis 2013; 7:107-112.
2. Hutfless SM, Weng X, Liu L, Allison J, Herrinton LJ. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003. Gastroenterology 2007; 133:1779-1786.
3. Sands BE, Cuffari C, Katz J, Kugathasan S, Onken J, Vitek C, Orenstein W. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis 2004; 10:677-692.
4. Tourner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008; 134:929-936.
5. Rahier JF, Ben-Horin S, Chowers Y, Conlon C, De Munter P, DHaens G, et al. European Crohns and Colitis Organisation (ECCO). European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2009; 3:47-91.
6. Rahier JF, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, et al. European Crohns and Colitis Organisation (ECCO). Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2014; 8:443-468.
7. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014; 58:309-318.
8. EderP, Łodyga M, Łykowska-Szuber L, Bartnik W, Durlik M, Gonciarz M, et al. Special guidelines for the management of ulcerative colitis. Recommendations of theWorking Group of the Polish National Consultant in Gastroenterology and the Polish Society of Gastroenterology. Prz Gastroenterol 2013; 8:1-20.
9. Melmed GY, Ippoliti AF, Papadakis KA, Tran TT, Birt JL, Lee SK, et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol 2006; 101:1834-1840.
10. Banaszkiewicz A, Klincewicz B, Łazowska-Przeorek I, Grzybowska-Chlebowczyk U, Kakol P, Mytyk A, et al. Influenza vaccination coverage in children with inflammatory bowel disease. Influenza Other Respir Viruses 2014; 8:431-435.
11. Yeung JH, Goodman KJ, Fedorak RN. Inadequate knowledge of immunization guidelines: a missed opportunity for preventing infection in immunocompromised IBD patients. Inflamm Bowel Dis 2012; 18:34-40.
12. Melmed GY, Agarwal N, Frenck RW, Ippoliti AF, Ibanez P, Papadakis KA, et al. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am J Gastroenterol 2010; 105:148-154.
13. Banaszkiewicz A, Radzikowski A. Efficacy, effectiveness, immunogenicity-Are not the same in vaccinology. World J Gastroenterol 2013; 19:7217-7218.
14. Rahier JF, Moutschen M, Van Gompel A, Van Ranst M, Louis E, Segaert S, et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford) 2010; 49:1815-1827.
15. Andrisani G, Frasca D, Romero M, Armuzzi A, Felice C, Marzo M, et al. Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants. J Crohns Colitis 2013; 7:301-307.
16. Cullen G, Bader C, Korzenik JR, Sands BE. Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease. Gut 2012; 61:385-391.
17. Romanowska M, Banaszkiewicz A, Nowak I, Radzikowski A, Brydak LB. Immunization against influenza during the 2005/2006 epidemic season and the humoral response in children with diagnosed inflammatory bowel disease (IBD). Med Sci Monit 2010; 16:CR433-CR439.
18. National Center for Immunisation and Respiratory Diseases. General recommendations on immunization-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60:1-64.
19. Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, et al. Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 2006; 55 (RR-17):1-37.
20. Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med 2013; 369:155-163.
21. Nakagomi O, Iturriza-Gomara M, Nakagomi T, Cunliffe NA. Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review. Expert Opin Biol Ther 2013; 13:1613-1621.
22. Anderson EJ, Weber SG. Rotavirus infection in adults. Lancet Infect Dis 2004; 4:91-99.
23. GlaxoSmithKline Inc. Rotarix. Product monograph. Available at: http://www. gsk.ca/english/docs-pdf/product-monographs/Rotarix.pdf. [Accessed 20 November 2014].
24. Merc Canada Inc. Rotateq. Product monograph. Available at: http://www. merck.ca/assets/en/pdf/products/RotaTeq-PM-E.pdf. [Accessed 20 November 2014].
25. Polish National Immunisation Programme 2014. Directive Ministry of Health. Available at: http://gistest.pis.gov.pl/ckfinder/userfiles/files/EP/informacje% 20dla%20podr%C3%B3%C5%BCuj%C4%85cych/PSO%202014.pdf. [Accessed 4 November 2013].
26. R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2013.
27. Ganczak M, Dmytrzyk-Danilw G, Karakiewicz B, Korzen M, Szych Z. Determinants influencing self-paid vaccination coverage, in 0-5 years old Polish children. Vaccine 2013; 31:5687-5692.
28. Nitsch-Osuch A, Kuchar E, Zycinska K, Topczewska-Cabanek A, Gyrczuk E, Wardyn K. Influenza vaccine coverage among children under the age of 5 years in Poland during 2004-2008. Eur J Med Res 2010; 15 (Suppl 2):102-104.